Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$40.02−1.65 (-3.96%)
Close on Nov 17, 2026Market cap $1.87BP/E –Yield –
Septerna price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Septerna's price to sales ratio was 22.4× on Nov 11, 2026, against 58.8× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 22.4× | −34.0 |
| 2025 | Dec 31, 2025 | 56.5× | −2.7 |
| 2024 | Dec 31, 2024 | 59.2× | – |
See a number that looks wrong?